Altogether, our findings strongly suggest that NSP3 (SH2D3C) promotes tumor immune evasion via dysfunctional T-cell phenotypes and T-cell exclusion mechanisms in lung cancer patients. This evidence concerns the gene SH2D3C and neoplasm.